Hypereosinophilic syndrome (HES) and related disorders represent a heterogeneous group of rare conditions marked by persistently elevated eosinophil counts that can lead to significant end‐organ ...
The evidence base for the risk and management of thrombosis in hematological malignancies patients The term Hypereosinophilic syndrome (HES) refers to a heterogeneous group of disorders characterised ...
SAN DIEGO — Researchers found JAK-STAT mutations in a predominance of a cohort of adults with fusion-free hypereosinophilia with features suggesting myeloid neoplasms, according to data presented at ...
No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2006 ASCO Annual Meeting. This abstract does not include a full text component. If you have the ...
Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on ...
MedPage Today on MSN
FDA Approves Mepolizumab for COPD
The FDA approved mepolizumab (Nucala) for adults with inadequately controlled chronic obstructive pulmonary disease (COPD), drugmaker GSK announced on Thursday. Labeling for the interleukin-5 (IL-5) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback